MaxCyte Inc share price logo

MaxCyte Inc

NASDAQ: MXCT

Small Cap

$1.06

+0.02

(+1.92%)

as on

MaxCyte Inc Stock Performance

as on May 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.00
    $1.07
    downward going graph

    5.66%

    Downside

    0.94%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.64
    $2.40
    downward going graph

    39.30%

    Downside

    126.42%

    Upside

    downward going graph

MaxCyte Inc share price movements today

Previous Close
$1.04
Open
$1.01
Volume
1.0M
Day's Low - High
$1.00 - $1.07
52 Week Low - High
$0.64 - $2.40

MaxCyte Inc Historical Returns

1 Month Return
+ 22.67 %
3 Month Return
+ 53.19 %
1 Year Return
-54.78 %
3 Year Return
-72.27 %
5 Year Return
0 %

MaxCyte Inc Stock Fundamentals & Key Indicators

Check MaxCyte Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$110.1M

EPS (TTM)

-0.275

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-34.2M

Revenue (TTM)

32.3M

Profit Margin

-121.16%

Return On Equity TTM

-21.30%

MaxCyte Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MaxCyte Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
MaxCyte Inc image
MaxCyte Inc
BUY$110.1MNANA-121.16%
Stryker Corporation image
Stryker Corporation
BUY$117.1B21.33%35.3213.21%
Boston Scientific Corp image
Boston Scientific Corp
BUY$79.6B26.12%22.4117.29%
Edwards Lifesciences Corp image
Edwards Lifesciences Corp
BUY$46.9B-9.65%43.9917.39%
Medtronic PLC image
Medtronic PLC
BUY$98.8B-39.49%21.513.00%
See all

Stock Returns calculator for MaxCyte Inc Stock including INR - Dollar returns

The MaxCyte Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

MaxCyte Inc investment value today

Current value as on today

₹51,994

Returns

-₹48,006

(-48.01%)

Returns from MaxCyte Inc Stock

-₹53,913 (-53.91%)

Dollar Impact

₹5,907 (+5.91%)

Analyst Recommendation on MaxCyte Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for MaxCyte Inc. Average target price of $4.11

MaxCyte Inc Share Price Target

Get share price movements and forecasts by analysts on MaxCyte Inc.

What analysts predicted

74.21%UPSIDE

Target Price

$4.11

Current Price

$1.06

Analyzed by

13 Analysts

Target

$4.11

MaxCyte Inc target price $4.11, a slight upside of 74.21% compared to current price of $1.06. According to 13 analysts rating.

Indian Investors' Interest in MaxCyte Inc Stock

Search interest for MaxCyte Inc Stock has increased by 80% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:80% versus previous 30 day period

MaxCyte Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
15
11
10
8
8
10
8
6
7
9
Gross Profit
14
9
8
6
6
8
6
6
5
8
Operating Income
-8
-12
-11
-14
-12
-12
-14
-10
-7
-6
EBITDA
-6
-11
-10
-12
-11
-11
-12
-11
-6
-5
Interest Expense
2
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
-
Income Before Tax
-5
-9
-9
-11
-10
-10
-12
-12
-9
-4
Income Tax Expense
0
1
-
-
-
-
-
-
-
-
Net Income
-5
-9
-9
-11
-10
-10
-12
-12
-9
-4
Net Profit Margin
-33.69%
-83.99%
-89.89%
-141.56%
-121.90%
-98.76%
-145.26%
-181.81%
-131.45%
-49.22%

MaxCyte Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
12
13
16
21
26
33
44
41
38
33
Gross Profit
10
12
14
19
23
30
39
36
31
26
Operating Income
-2
-9
-8
-12
-11
-18
-27
-48
-51
-45
EBITDA
-2
-9
-7
-11
-9
-16
-24
-44
-46
-40
Interest Expense
0
0
0
0
0
1
0
-
-
-
Depreciation
-
0
0
0
1
1
2
3
4
5
Income Before Tax
-3
-9
-8
-12
-11
-19
-23
-37
-41
-44
Income Tax Expense
0
-
0
0
0
1
-3
4
-
-
Net Income
-3
-9
-8
-12
-11
-19
-23
-37
-41
-44
Net Profit Margin
-27.27%
-70.91%
-53.21%
-59.64%
-45.15%
-56.30%
-53.25%
-91.85%
-106.29%
-135.14%

MaxCyte Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-9
-9
-11
-10
-10
-12
-12
-9
-4
Operating Cash Flow
-10
-4
-4
-7
-14
-9
-7
-2
-8
Investing Cash Flow
-14
19
3
-1
9
1
5
9
2
Financing Cash Flow
0
0
0
0
0
0
0
0
0
Change in Cash
-24
15
0
-9
-4
-8
-2
7
-5

MaxCyte Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-8
-12
-11
-19
-23
-37
-41
-44
Operating Cash Flow
-9
-10
-8
-8
-10
-14
-21
-27
-34
Investing Cash Flow
0
-3
0
-16
-195
-24
54
6
25
Financing Cash Flow
23
0
12
28
234
2
2
2
0
Change in Cash
13
-14
3
3
29
-36
35
-18
-7

Global Institutional Holdings in MaxCyte Inc

Funds
Holdings
Rice Hall James & Associates, LLC
0.39%
Jane Street Group LLC
0.49%
Morgan Stanley - Brokerage Accounts
4.14%
Mudita Advisors LLP
3.15%
State Street Corp
2.2%
See all

Insights on MaxCyte Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -12.41M → -4.75M (in $), with an average increase of 65.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 6.82M → 9.65M (in $), with an average increase of 15.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MXCT stock has moved up by 26.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, MaxCyte, Inc. Common Stock has experienced a drawdown of -72.8%, however Stryker Corporation resisted the overall trend and outperformed by 65.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 4.3% return, outperforming this stock by 58.7%

About MaxCyte Inc

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
OrganisationMaxCyte Inc
Headquarters9713 Key West Avenue, Rockville, MD, United States, 20850
IndustryMedical Devices
CEOMr. Maher Masoud
E-voting on sharesClick here to vote

Key Management of MaxCyte Inc

Name

Title

Ms. Ana-Paula Martins Fernandes

Senior Vice President of Global Sales

Ms. Jill Mayer

Senior Vice President of Human Resources

Mr. Maher Masoud

President, CEO & Executive Director

Mr. Parmeet Ahuja

Chief Financial Officer

Mr. Jay Gelfman

Chief Operations Officer

Mr. Jack Horgan

Senior Vice President of Corporate Development

FAQs

What is MaxCyte Inc share price today?

MaxCyte Inc share price today is $1.06 as on at the close of the market. MaxCyte Inc share today touched a day high of $1.07 and a low of $1.

What is the 52 week high and 52 week low for MaxCyte Inc share?

MaxCyte Inc share touched a 52 week high of $2.4 on and a 52 week low of $0.64 on . MaxCyte Inc stock price today i.e. is closed at $1.06,which is 55.83% down from its 52 week high and 64.75% up from its 52 week low.

What is MaxCyte Inc's market capitalisation today?

MaxCyte Inc market capitalisation is $0.00T as on .

How to invest in MaxCyte Inc Stock (MXCT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for MaxCyte Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in MaxCyte Inc Shares that will get you 1.4151 shares as per MaxCyte Inc share price of $1.06 per share as on May 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy MaxCyte Inc Stock (MXCT) from India?

Indian investors can start investing in MaxCyte Inc (MXCT) shares with as little as ₹96.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.35 in MaxCyte Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on MaxCyte Inc share’s latest price of $1.06 as on May 19, 2026 at 8:45 am IST, you will get 9.4340 shares of MaxCyte Inc. Learn more about fractional shares .